Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Gastritis Treatment Market has now become a central focus in the field of gastrointestinal health, reflecting the rising number of people living with gastritis- this is what happens when your stomach lining gets inflamed. This market is driven by various treatment options which range from alleviating symptoms, healing and preventing the advancement of this common digestive disorder. Gastritis may occur due to several reasons including bacterial infections, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), excessive alcohol consumption and stress; hence, quantum has come up with pharmaceuticals; lifestyle modifications; supportive therapies to help address all those aspects contributing to gastritis.
The Gastritis Treatment Market heavily relies on pharmacological approaches for intervention where many medicines are designed to address different aspects of the condition. Proton pump inhibitors (PPIs) as well as histamine-2 blockers are commonly prescribed for reducing stomach acid production thus relieving patients from immediate symptoms and helping their stomach linings heal faster if they were injured. In situations where bacterial infections particularly helicobacter pylori have been identified as causal agents, antibiotics are utilized. Additionally, antacids and cytoprotective agents are used to manage symptoms and protect the stomach lining.
Lifestyle changes comprise an important part of managing gastritis and emphasize dietary modifications, stress reduction techniques and avoidance of triggers. As such, it encourages easy-to-digest balanced diet that discourages spicy foods from being consumed by clients while also discouraging too much caffeine intake besides alcoholism. Smoking cessation as well as stress management mechanisms represent some aspects upon which a comprehensive approach towards treating gastritis is built since lifestyle usually affects digestive health.
Geographically, regions covered by this market include globally spread areas where cultural practices along with dietary habits influence prevalence rates for gastritis symptoms in population groups while at the same time impacting on healthcare systems. Before now North America/Europe had dominated this market owing mostly to a highly informed public in matters of health, but currently Latin America and Asia-pacific are emerging as major players due to growing awareness about gastrointestinal health and Westernization process. The market dynamics also depend on availability of OTC drugs as well as accessibility of healthcare services across various regions.
Challenges within the Gastritis Treatment Market include the potential for recurrent episodes, particularly in chronic cases, and the need for long-term management strategies. There are continuous efforts that have been put in place to educate patients more so when it comes to adherence with prescribed treatment plans, lifestyle changes or follow up care so as to reduce chances of gastritis returning again and related complications.
In future, the Gastritis Treatment Market is set for further growth that will be largely driven by ongoing research activities. Research into new therapeutic agents such as anti-inflammatory medications and mucosal protective agents has shown promise in terms of expanding treatment options. On the other hand, advances made in diagnostic techniques including endoscopy have contributed towards accurate diagnosis hence more focused treatment approaches.
Gastritis Treatment Market Highlights:
Gastritis Treatment Market Scenario
The Gastritis Treatment Market is anticipated to reach USD 244.23 Million by 2030 at 4.30% CAGR during the forecast period 2022-2030. Gastritis is characterized by a set of conditions that cause inflammation or irritation of the lining of the stomach, for a short or long time. Upper abdominal pain or discomfort is the most common symptom of Gastritis. Gastritis has been broadly categorized into three segments, namely, acute gastritis, chronic gastritis, and erosion of metaplasia or atrophic gastritis. The market for gastritis treatment is expanding worldwide due to drivers such as increasing occurrence of acute and chronic gastritis, advances in the area of medical technologies, increasing fast food chains worldwide, massive adoption of a sedentary lifestyle, and advancement in endoscopy devices that increased the accuracy of diagnosis. Moreover, chronic gastritis patients, rely on acidity reducing medicines for a lifetime, thus fueling the market demand which in turn would boost up the market growth. However, unaffordability and lack of advanced medical device technology in middle-income countries are likely to hamper the gastritis treatment market growth.
Research Methodology:
Source: World Health Organization, Centers for Disease Control and Prevention, American Heart Association, National Institute of Health, American College of Cardiology, European Heart Network, expert interview, annual report, white paper, company presentation and market research future analysis
Market Players
- Abbott Laboratories
- AstraZeneca PLC
- Novartis AG
- Microbiotix, Inc
- Reddy’s Laboratories
- Lupin Ltd
- Perrigo Pharmaceutical
- Cipla Inc.
- Pfizer Inc.
- SUN Pharmaceuticals Industries limited
Market Segmentation
The gastritis treatment market is segmented on the basis of diagnosis, treatment type, drug distribution channel, and end-users.
Considering the diagnosis, the market is segmented into blood test, endoscopy, x-ray of the upper digestive system and others.
By treatment type, the gastritis treatment market is segmented into acid-blocking medicines, antibiotics, antacids, and histamine blockers.
With reference to the drug distribution channel, the gastritis treatment market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy.
On account of end-users, the gastritis treatment market is segmented hospitals & clinics and others.
Based on region the market is segmented into Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Regional Market Summary
The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market. Moreover, rising alcohol abuse, the presence of prominent key players is likely to spur the market growth. For instance, According to a published survey, approximately 1 in 100 is a victim of gastritis in the US. Thus, this increasing patient pool will enhance the market growth during the forecasted period. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of gastritis treatment market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) US health care spending increased 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, the increasing per capita income of individuals, as well as rising healthcare spending, will aid up the market growth of the Americas.
Europe is the second market leader and holds a healthy share in the gastritis treatment market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of a flourishing medical device market which helps in efficient and accurate diagnosis. Furthermore, due to the increasing number of lactose-intolerant issues, vulnerability to falling prey of gastritis is more likely to lead to an increasing number of gastritis sufferers. Thus, fueling the market growth during the forecast period.
Asia-Pacific is expected to be the fastest emerging market owing to increasing government initiatives for healthcare reform, increasing adaption of a sedentary lifestyle, and increasing prevalence of gastritis. Moreover, the prevalence of multifocal atrophic gastritis and gastric adenocarcinomas is high in these regions. Furthermore, the presence of renowned domestic pharmaceutical players, as well as the increasing healthcare spending per capita, is going to accelerate the market growth during the forecast period.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. With an increasing number of gastrointestinal disorders region in this region, many key players are willing to set up their research and development centers to find a cure for these diseases. Moreover, the government is aiming at improving the healthcare infrastructure. Thus, a steady growth rate might be seen during the forecast period.
Gastritis Treatment Market Share (%), by Region, 2017
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis
Market Segmentation & Key players
Gastritis Treatment Market, by Diagnosis
- Blood test
- Endoscopy
- X-ray of upper digestive system
- Others
Gastritis Treatment Market, by Treatment type
- Acid-blocking medicines
- Antibiotics
- Antacids
- Histamine Blockers
Gastritis Treatment Market, by Drug Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Gastritis Treatment Market, by End-User
- Hospital & Clinics
- Others
Gastritis treatment Market, By Region
North America
- US
- Canada
South America
Europe
- Western Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia-Pacific
Middle East and Africa
- United Arab Emirates
- Saudi Arabia
- Oman
- Kuwait
- Qatar
- Rest of the Middle East & Africa
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
